The global landscape for pharmacological optimization and the structural “refactoring” of the human central nervous system has reached a stunning peak in 2026. As elite researchers and dedicated patients across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, Netherlands, Germany, and Switzerland seek to navigate the complexities of end-of-life care and […]